Charles Schwab’s LeonaBio Inc LONA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-1,386
Closed -$40.9K 3578
2023
Q2
$40.9K Sell
1,386
-8,124
-85% -$231K ﹤0.01% 3445
2023
Q1
$238K Buy
9,510
+630
+7% +$20.3K ﹤0.01% 3130
2022
Q4
$282K Hold
8,880
﹤0.01% 3128
2022
Q3
$264K Hold
8,880
﹤0.01% 3130
2022
Q2
$271K Buy
8,880
+340
+4% +$31.2K ﹤0.01% 3202
2022
Q1
$1.15M Buy
8,540
+85
+1% +$8.96K ﹤0.01% 2798
2021
Q4
$1.1M Buy
8,455
+278
+3% +$35.2K ﹤0.01% 2872
2021
Q3
$767K Sell
8,177
-7,022
-46% -$715K ﹤0.01% 2979
2021
Q2
$1.56M Buy
15,199
+4,072
+37% +$711K ﹤0.01% 2794
2021
Q1
$2.05M Buy
11,127
+2,752
+33% +$607K ﹤0.01% 2656
2020
Q4
$2.87M Buy
+8,375
New +$1.98M ﹤0.01% 2472

Other funds holding LONA

Charles Schwab's LONA Position: Q3 2023 in Review

Charles Schwab sold out of LeonaBio Inc (LONA) in Q3 2023, closing a stake of 1,386 shares — an estimated $40.9K sold.

Charles Schwab first reported a position in LONA in Q4 2020 and held it in 11 quarters. The position peaked at $2.87M in Q4 2020. 70 funds tracked by Wall St. Rank hold LONA as of Q3 2023.

  • Charles Schwab reported no remaining LeonaBio Inc position as of Q3 2023 after selling out during the quarter.
  • Charles Schwab sold 1,386 LeonaBio Inc shares in Q3 2023, an estimated $40.9K.
  • Charles Schwab first reported a position in LeonaBio Inc in Q4 2020 and held it in 11 quarters.
  • Charles Schwab's LeonaBio Inc position peaked at $2.87M in Q4 2020.
  • 70 funds tracked by Wall St. Rank held LeonaBio Inc as of Q3 2023.

Based on Charles Schwab's 13F filing for Q3 2023, filed 8 Nov 2023.